Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 26281-26290 Newer>

The Motley Fool September 25, 2007 Brian Lawler	Acorda at a Glance Acorda Therapeutics has given astute biotech investors quite a ride over the last 12 months following positive results for their lead drug, Fampridine-SR. That drug now takes another step towards FDA approval. Investors, take note.
The Motley Fool September 25, 2007 Billy Fisher	Bristol-Myers Buys In to Biologics Looking to advance its biologics strategy, Bristol-Myers Squibb announces it will acquire Adnexus Therapeutics, a privately held developer of biologics.
The Motley Fool September 25, 2007 Anders Bylund	Foolish Forecast: Corel's Brilliant Buy In advance of earnings reports, analysts expect the software developer to show a significant increase in sales, thanks to two wise acquisitions.
The Motley Fool September 25, 2007 Brian Orelli	Stocks and the Seven-Year Itch It's a good idea to re-evaluate your holdings occasionally, perhaps after each earnings report, and let go any stocks that have become overvalued.
The Motley Fool September 25, 2007 Anders Bylund	Tektronix Tackles Good Debt The builder of test and monitoring equipment wisely emulates giants like IBM, taking on debt to buy back stock. Investors, take note.
The Motley Fool September 25, 2007 Rich Smith	Quick Take: First Horizon Limits Its Horizons First Horizon decides to retrench in its home market of Tennessee, focusing on its First Tennessee brand, and has successfully negotiated the sale of all 34 of its First Horizon bank branches.
The Motley Fool September 25, 2007 Anders Bylund	Limping Lennar: Fool by Numbers The fast facts on Lennar's dismal third-quarter results, as the effects of the housing crisis take their toll on the homebuilder.
The Motley Fool September 25, 2007 Ryan Fuhrmann	Fool on the Street: Grilling Benihana The teppanyaki titan tempts investors with three different restaurant concepts. With ambitious growth plans, this may be a restaurant chain to watch.
The Motley Fool September 25, 2007 Ryan Fuhrmann	Fool on the Street: The Secret of Kohl's Success The retailer updates investors on current ambitions and the secrets to its success.
The Motley Fool September 25, 2007 Seth Jayson	Quick Take: Golf Clap for Lennar Homebuilder Lennar presents their horrible quarterly numbers with a straightforward approach.
<Older 26281-26290 Newer> Return to current articles.